Kane Biotech Inc.
KNE.V
Price:
$0.035
Market Cap:
$5.86M
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorpo...[Read more]
Industry
Biotechnology
IPO Date
2003-10-01
Stock Exchange
TSXV
Ticker
KNE.V
PE Ratio
[-3.50]
ROE
[205.41%]
Current Ratio
[0.90]
Dividend Yield
[0%]
Enterprise Value
[7.22M]
Dividend History
The ROE as of December 2025 (TTM) for Kane Biotech Inc. (KNE.V) is 205.41%
According to Kane Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is 205.41%. This represents a change of 158.07% compared to the average of 79.59% of the last 4 quarters.
Kane Biotech Inc. (KNE.V) Historical ROE (quarterly & annually)
How has KNE.V ROE performed in the past?
The mean historical ROE of Kane Biotech Inc. over the last ten years is 23.04%. The current 205.41% ROE has changed 791.66% with respect to the historical average. Over the past ten years (40 quarters), KNE.V's ROE was at its highest in in the June 2019 quarter at 3.70%. The ROE was at its lowest in in the June 2024 quarter at -1272.35%.
Average
23.04%
Median
53.66%
Minimum
-356.07%
Maximum
331.12%
Kane Biotech Inc. (KNE.V) ROE by Quarter and Year
Discovering the peaks and valleys of Kane Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.35%
Maximum Annual ROE = 331.12%
Minimum Annual Increase = -425.40%
Minimum Annual ROE = -356.07%
| Year | ROE | Change |
|---|---|---|
| 2024 | 185.64% | 289.35% |
| 2023 | 47.68% | -20.05% |
| 2022 | 59.64% | -49.67% |
| 2021 | 118.49% | -52.51% |
| 2020 | 249.51% | -317.45% |
| 2019 | -114.74% | -134.65% |
| 2018 | 331.12% | -425.40% |
| 2017 | -101.76% | -46.20% |
| 2016 | -189.15% | -46.88% |
| 2015 | -356.07% | 192.13% |
Kane Biotech Inc. (KNE.V) Average ROE
How has KNE.V ROE performed in the past?
The current ROE of Kane Biotech Inc. (KNE.V) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
97.65%
5-year avg
132.19%
10-year avg
23.04%
Kane Biotech Inc. (KNE.V) ROE vs. Peers
How is KNE.V’s ROE compared to its peers?
Kane Biotech Inc.’s ROE is less than Aptose Biosciences Inc. (123.88%), greater than Avricore Health Inc. (-71.13%), greater than Telo Genomics Corp. (-322.33%), less than 1933 Industries Inc. (5.09%), less than Appili Therapeutics Inc. (17.71%), greater than Mountain Valley MD Holdings Inc. (-222.32%), greater than CanadaBis Capital Inc. (-10.43%), greater than XORTX Therapeutics Inc. (-73.46%), less than Restart Life Sciences Corp. (404.52%), greater than Therma Bright Inc. (-740.74%),
| Company | ROE | Market cap |
|---|---|---|
| 123.88% | $5.31M | |
| -71.13% | $5.06M | |
| -322.33% | $5.02M | |
| 5.09% | $7.44M | |
| 17.71% | $2.43M | |
| -222.32% | $5.29M | |
| -10.43% | $3.46M | |
| -73.46% | $3.22M | |
| 404.52% | $4.02M | |
| -740.74% | $2.61M |
Build a custom stock screener for Kane Biotech Inc. (KNE.V) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kane Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kane Biotech Inc. (KNE.V) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kane Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kane Biotech Inc.'s ROE?
How is the ROE calculated for Kane Biotech Inc. (KNE.V)?
What is the highest ROE for Kane Biotech Inc. (KNE.V)?
What is the 3-year average ROE for Kane Biotech Inc. (KNE.V)?
What is the 5-year average ROE for Kane Biotech Inc. (KNE.V)?
How does the current ROE for Kane Biotech Inc. (KNE.V) compare to its historical average?